Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial.

被引：0

作者：

Selvaraj, Senthil ^{[1
]}

Claggett, Brain ^{[2
]}

Shah, Sanjiv ^{[3
]}

Anand, Inder ^{[4
,5
]}

Rouleau, Jean ^{[6
]}

O'Meara, Eileen ^{[6
]}

Desai, Akshay ^{[2
]}

Lewis, Eldrin ^{[2
]}

Pitt, Bertram ^{[7
]}

Sweitzer, Nancy ^{[8
]}

Fang, James ^{[9
]}

Solomon, Scott ^{[2
]}

机构：

[1] Hosp Univ Penn, Cardiol, 3400 Spruce St, Philadelphia, PA 19104 USA

[2] Brigham & Womens Hosp, Cardiol, 75 Francis St, Boston, MA 02115 USA

[3] Northwestern Univ, Chicago, IL 60611 USA

[4] VA Med Ctr, Cardiol, Minneapolis, MN USA

[5] Univ Minnesota, Minneapolis, MN USA

[6] Univ Montreal, Montreal Heart Inst, Med, Montreal, PQ, Canada

[7] Univ Michigan, Cardiol, Ann Arbor, MI 48109 USA

[8] Sarver Heart Ctr, Cardiol, Tucson, AZ USA

[9] Univ Utah, Cardiol, Salt Lake City, UT USA

来源：

CIRCULATION | 2018年 / 138卷

关键词：

Heart failure; Aldosterone; Hypertension; Renal function;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A10530

引用

页数：2

共 50 条

[31] Spironolactone, fibrosis and heart failure with preserved ejection fraction
Reddy, Yogesh N. V.
Sundaram, Varun
EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (09) : 1569 - 1572
[32] Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial
Wu, Yuzhong
Zhu, Wengen
He, Xin
Xue, Ruicong
Liang, Weihao
Wei, Fangfei
Wu, Zexuan
Zhou, Yuanyuan
Wu, Dexi
He, Jiangui
Dong, Yugang
Liu, Chen
BRITISH JOURNAL OF GENERAL PRACTICE, 2021, 71 (702): : E62 - E70
[33] Mechanistic Effects of Spironolactone on Cardiovascular and Renal Biomarkers in Heart Failure With Preserved Ejection Fraction A TOPCAT Biorepository Study
Myhre, Peder L.
Vaduganathan, Muthiah
O'Meara, Eileen
Claggett, Brian L.
de Denus, Simon
Jarolim, Petr
Anand, Inder S.
Pitt, Bertram
Rouleau, Jean L.
Solomon, Scott D.
Pfeffer, Marc A.
Desai, Akshay S.
CIRCULATION-HEART FAILURE, 2020, 13 (01) : E006638
[34] Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
Lin, Tin-Kwang
Hsu, Bo-Cheng
Li, Yi-Da
Chen, Chi-Hsien
Lin, Jiunn-Wen
Chien, Chen-Yu
Weng, Chia-Ying
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (12):
[35] Influence of Age on the Efficacy and Safety of Spironolactone in Heart Failure with Preserved Ejection Fraction
Vardeny, Orly
Vaduganathan, Muthiah
Claggett, Brian
Desai, Akshay S.
Anand, Inder S.
Shah, Sanjiv J.
O'Meara, Eileen
Lewis, Eldrin F.
Rouleau, Jean
Pitt, Bertram
Pfeffer, Marc A.
Solomon, Scott D.
JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S12 - S12
[36] Machine Learning Identifies Heterogeneity of Treatment Effect for the Use of Spironolactone in Heart Failure With Preserved Ejection Fraction: Insights From the TOPCAT Trial
Tahir, Usman A.
Hu Yang
Sabe, Marwa
Yeh, Robert W.
Shen Changyu
CIRCULATION, 2018, 138
[37] PERSONALIZING THE THERAPEUTIC BENEFIT FROM SPIRONOLACTONE IN HEART FAILURE WITH PRESERVED EJECTION FRACTION THROUGH COMPUTATIONAL PHENOMAPS OF THE TOPCAT TRIAL AND MACHINE LEARNING
Oikonomou, Evangelos K.
Suchard, Marc
Khera, Rohan
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 424 - 424
[38] Prognostic implications of impaired glucose metabolism and albuminuria in heart failure with preserved ejection fraction
Weerts, J.
Aizpurua, A. Barandiaran
Mourmans, S. G. J.
Brunner-La Rocca, H. P.
Knackstedt, C.
Van Empel, V. P. M.
EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 17 - 18
[39] Prognostic value of BNP in heart failure with preserved or reduced ejection fraction
Bosseau, Christian
Galli, Elena
Donal, Erwan
HEART, 2015, 101 (23) : 1855 - 1856
[40] Prognostic Value of Ventilatory Power In Heart Failure with Preserved Ejection Fraction
Giverts, Ilya
Poltavskaya, Maria
Serova, Maria
Dikur, Oxana
Kuzmina, Ekaterina
Suchkova, Svetlana
Syrkin, Abram
JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S115 - S115

← 1 2 3 4 5 →